Jazz Pharmaceuticals PLC at Wells Fargo Healthcare Conference Transcript
Hi, everyone. We're going to go on to the next session. My name is Jacob Hughes. I'm the senior specialty pharmaceutical analyst at Wells Fargo Securities.
I'm extremely pleased to have the entire Jazz team here today. We have Kim, Renee and Rob here. I think this is a really exciting time for Jazz as they've built out the pipeline, delevered the balance sheet and have announced some 2025 targets. So I'm going to hand it over to Renee to give a brief intro, and then we'll jump into Q&A. And through the conversation, if you have additional questions, please chime in.
Great. Thanks, Jake, and thank you for having us. We're thrilled to be here. Just briefly before we get started, we will be making forward-looking statements today. These are all subject to risks, and please see our SEC filings for more information.
Also, we may reference non-GAAP financial measures. Full reconciliations are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)